Clinical Trials Directory

Trials / Completed

CompletedNCT00540267

Bone Density in Patients With Schizophrenia

Bone Mineral Density in the Korean Patients With Chronic Schizophrenia With Alcohol Abuse

Status
Completed
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Inje University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

People with chronic mental disorder such as schizophrenia and alcohol abuse are high risk groups for developing osteoporosis. To evaluate the prevalence of bone mineral density in men patients with schizophrenia with alcohol abuse, the investigators will compare bone mineral density between patient with schizophrenia with and without alcohol abuse.

Detailed description

People with schizophrenia has been known as a high risk groups for developing osteoporosis, because of lack of exercise, poor nutrition and high rate of smoking. Those with alcohol abuse may be higher risk group than one with schizophrenia without alcohol abuse, because they frequently have several medical problems such as liver dysfunction, Vitamin D deficiency, hyperparathyroidism and those medical condition increase risk for developing osteoporosis. Also alcohol itself can increase bone loss too by disturbing bone remodeling and enhancing bone fragility. To compare the prevalence of bone mineral density in patients with schizophrenia with alcohol abuse to those without alcohol problem, we will investigate BMD in large population of Korean patients with those illnesses.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionNo Intervention

Timeline

Start date
2007-11-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2007-10-05
Last updated
2008-11-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00540267. Inclusion in this directory is not an endorsement.